Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status
ObjectiveThe application of radiofrequency ablation (RFA) for recurrent thyroid cancer has been demonstrated to effectively manage lesions at critical locations, such as abutting the trachea, with limited complications. Comprehensive investigation of both biochemical (B) and structural (S) change af...
Main Authors: | Wen-Chieh Chen, Chen-Kai Chou, Yen-Hsiang Chang, Pi-Ling Chiang, Lay-San Lim, Shun-Yu Chi, Sheng-Dean Luo, Wei-Che Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.933931/full |
Similar Items
-
One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan
by: Lay San Lim, et al.
Published: (2022-08-01) -
Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
by: Pi-Ling Chiang, et al.
Published: (2023-10-01) -
Cooled radiofrequency ablation of cervical medial branches for treatment of facetogenic pain
by: Nithya Dinesh, et al.
Published: (2022-01-01) -
Radiofrequency Ablation for Adenomyosis
by: Ioannis Dedes, et al.
Published: (2023-04-01) -
Transcervical radiofrequency ablation of focal adenomyosis: pilot results
by: Elvin Piriyev, et al.
Published: (2023-12-01)